Justification of continuous packed-bed reactor for retroviral vector production from amphotropic PsiCRIP murine producer cell
- PMID: 19003389
- PMCID: PMC3449741
- DOI: 10.1023/A:1008120313175
Justification of continuous packed-bed reactor for retroviral vector production from amphotropic PsiCRIP murine producer cell
Abstract
To indentify a plausible large-scale production system forretroviral vector, three culture systems, i.e., batch culturewith medium exchange, microcarrier culture, and packed-bedreactor culture were compared. In batch cultures with mediumexchange, high cell concentrations were maintained for about amonth, and the harvested retroviral titer remained constant. Inmicrocarrier cultures, although cell growth was rapid, theretroviral titer was unexpectedly low, suggesting that the lowtiter was due either to serious damage to the retroviral vectoror to a reduction in the production rate of retroviral vector,caused by mechanical shear forces. Although the retroviral titer(maximum titer, 1.56 x 10(6)) in the packed-bedreactor was a little bit lower than that obtained in the batchculture with medium exchange (maximum titer, 1.91 x10(6)), continuous production made it possible to increasethe cumulative titer up to 16-fold of that from the batchculture with medium exchange. Moreover, as the packed-bedreactor system requires less labor and shows excellentvolumetric productivity in comparison to batch cultures withmedium exchanges, it will be an appropriate production systemfor retroviral vector in large quantities.
Similar articles
-
Kinetics of retroviral production from the amphotropic ΨCRIP murine producer cell line.Cytotechnology. 1996 Jan;22(1-3):185-95. doi: 10.1007/BF00353938. Cytotechnology. 1996. PMID: 22358929
-
Comparison of different bioreactor systems for the production of high titer retroviral vectors.Biotechnol Prog. 2001 Mar-Apr;17(2):326-35. doi: 10.1021/bp000162z. Biotechnol Prog. 2001. PMID: 11312711
-
Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production.Gene Ther. 1995 Dec;2(10):723-30. Gene Ther. 1995. PMID: 8750011
-
Generation of high-titer pseudotyped retroviral vectors with very broad host range.Methods Cell Biol. 1994;43 Pt A:99-112. doi: 10.1016/s0091-679x(08)60600-7. Methods Cell Biol. 1994. PMID: 7823872 Review.
-
State-of-the-art of the production of retroviral vectors.J Gene Med. 2004 Feb;6 Suppl 1:S105-24. doi: 10.1002/jgm.499. J Gene Med. 2004. PMID: 14978755 Review.
Cited by
-
Cell culture processes for the production of viral vectors for gene therapy purposes.Cytotechnology. 2006 Mar;50(1-3):141-62. doi: 10.1007/s10616-005-5507-z. Epub 2006 Jun 30. Cytotechnology. 2006. PMID: 19003076 Free PMC article.
References
-
- Andreadis ST, Roth CM, Le Doux JM, Morgan JR, Yarmush ML. Large-scale processing of recombinant retroviruses for gene therapy. Biotechnol Prog. 1999;15:1–11. - PubMed
-
- Chiou TW, Murakami S, Wang DIC. A fiber-bed bioreactor for anchorage-dependent animal cell culture: Part I. Bioreactor design and operations. Biotechnol Bioeng. 1991;37:755–761. - PubMed
-
- Chuck AC, Palsson BO. Consistent and high rate of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. Hum Gene Ther. 1996;7:743–750. - PubMed
-
- Croughan MS, Hamel JF, Wang DIC. Hydrodynamic effects on animal cells grown in microcarrier cultures. Biotechnol Bioeng. 1987;29:130–141. - PubMed
LinkOut - more resources
Full Text Sources